| Active ingredient (INN) | Oseltamivir |
|---|---|
| Brand names | Tamiflu, Ebilfumin |
| ATC level 5 | J05AH02 |
| ATC level 4 | J05AH |
| Drug class | Neuraminidase inhibitor |
| Therapeutic category | Anti-infective |
| Strength | 30mg · 45mg · 75mg |
| Dosage form | capsule · oral suspension |
| Route of administration | oral |
| WHO Essential Medicine | Yes (2023) |
| Controlled substance | No |
| Marketing-authorisation holders | Lupin Australia Pty Limited, Alembic Pharmaceuticals Australia Pty Ltd, TEVA PHARMACEUTICALS USA, INC., Roche Products Pty Ltd +1 more |
| Registrations on file | 30 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| Lupin | 75 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| Lupin | 30 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| Gh | 45 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| Gh | 30 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| Gh | 75 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| Lupin | 45 mg | — | 🇦🇺 AU | Lupin Australia Pty Limited | Active |
| OSMIVIR oseltamivir | 75 mg | — | 🇦🇺 AU | — | Active |
| Strides | 75 mg | — | 🇦🇺 AU | — | Active |
| OSMIVIR oseltamivir | 45 mg | — | 🇦🇺 AU | — | Active |
| Strides | 45 mg | — | 🇦🇺 AU | — | Active |
| Str | 75 mg | — | 🇦🇺 AU | — | Active |
| Str | 30 mg | — | 🇦🇺 AU | — | Active |
| Alembic | 30 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| ALEMVIR oseltamivir | 75 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |
| ALEMVIR oseltamivir | 45 mg | — | 🇦🇺 AU | Alembic Pharmaceuticals Australia Pty Ltd | Active |